Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease

被引：0
|
作者：
Sugiyama, Seigo [1 ]
Ogawa, Hisao [1 ]
机构：
[1] Kumamoto Univ, Kumamoto, Japan
来源：
CIRCULATION | 2006年 / 114卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：849 / 849
页数：1
相关论文
共 50 条
  • [1] Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease
    Sugiyama, Seigo
    Fukushima, Hironobu
    Kugiyama, Kiyotaka
    Maruyoshi, Hidetomo
    Kojima, Sunao
    Funahashi, Tohru
    Sakamoto, Tomohiro
    Horibata, Yoko
    Watanabe, Keisuke
    Koga, Hidenobu
    Sugamura, Koichi
    Otsuka, Fumiyuki
    Shimomura, Iichirou
    Ogawa, Hisao
    ATHEROSCLEROSIS, 2007, 194 (02) : E43 - E51
  • [2] Lower plasma levels of adiponectin are associated with impaired glucose tolerance and coronary artery disease in non-diabetic men
    Otsuka, F
    Sugiyama, S
    Kojima, S
    Maruyoshi, H
    CIRCULATION, 2005, 112 (17) : U844 - U844
  • [3] Adiponectin and the development of diabetes in patients with coronary artery disease and impaired fasting glucose
    Knobler, H
    Benderly, M
    Boyko, V
    Behar, S
    Matas, Z
    Rubinstein, A
    Raz, I
    Wainstein, J
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2006, 154 (01) : 87 - 92
  • [4] Plaque Characteristics in Coronary Artery Disease Patients with Impaired Glucose Tolerance
    Suzuki, Keishi
    Takano, Hitoshi
    Kubota, Yoshiaki
    Inui, Keisuke
    Nakamura, Shunichi
    Tokita, Yukichi
    Kato, Koji
    Asai, Kuniya
    Shimizu, Wataru
    PLOS ONE, 2016, 11 (12):
  • [5] Impaired glucose metabolism in patients with newly diagnosed coronary artery disease
    Gotsis, A.
    Bozia, P.
    Dourtsiou, S.
    Labrou, A.
    Papadopoulou, L.
    Savvopoulou, A.
    Borghi, L.
    Theodoridis, D.
    Karras, S.
    Panagiotidou, A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 353 - 354
  • [6] The effects of hypertension and impaired glucose metabolism in patients with coronary artery disease
    Gotsis, A
    Karakiriou, M
    Bozia, P
    Labrou, A
    Kyrkoudis, A
    Marinos, E
    Borghi, L
    Karagkiozaki, V
    Savvopoulou, A
    Panagiotidou, A
    JOURNAL OF HYPERTENSION, 2004, 22 : S402 - S403
  • [7] Adiponectin in coronary heart disease and newly diagnosed impaired glucose tolerance
    Ghanbari, Aline Azizi
    Doerr, Rolf
    Spitzer, Stefan
    Stumpf, Juergen
    Britz, Andreas
    Amann-Zalan, Ildiko
    Lodwig, Volker
    Ulm, Bernhard
    Schnell, Oliver
    Lohmann, Tobias
    DIABETES & VASCULAR DISEASE RESEARCH, 2013, 10 (05): : 452 - 458
  • [8] Impact of impaired glucose tolerance on clopidogrel response in patients with coronary artery disease
    Ueno, Masafumi
    Fujita, Kosuke
    Yamamoto, Hiroyuki
    Ikeda, Tomoyuki
    Suga, Tatsuya
    Yamaji, Kenji
    Ikuta, Shinichiro
    Kobuke, Kazuhiro
    Iwanaga, Yoshitaka
    Angiolillo, Dominick J.
    Miyazaki, Shunichi
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2015, 40 (02) : 174 - 181
  • [9] Impact of impaired glucose tolerance on clopidogrel response in patients with coronary artery disease
    Masafumi Ueno
    Kosuke Fujita
    Hiroyuki Yamamoto
    Tomoyuki Ikeda
    Tatsuya Suga
    Kenji Yamaji
    Shinichiro Ikuta
    Kazuhiro Kobuke
    Yoshitaka Iwanaga
    Dominick J. Angiolillo
    Shunichi Miyazaki
    Journal of Thrombosis and Thrombolysis, 2015, 40 : 174 - 181
  • [10] Inflammatory markers in patients with stable coronary artery disease and impaired glucose tolerance
    Saely, CH
    Aczel, S
    Marte, T
    Langer, P
    Moll, W
    Drexel, H
    DIABETES, 2004, 53 : A186 - A186
12345